H&P, Triad Group Must Comply to FDA’s Consent Decree for Quality Improvements

The FDA has filed a consent decree against H&P Industries, The Triad Group and three individuals that prevents them from manufacturing and distributing products from their facilities until meeting certain quality requirements, according to an FDA news release.

Advertisement

Read the full report in Becker’s ASC Review on FDA’s consent decree against H&P Industries and The Triad Group.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.